Skip to main content

CORRECTION article

Front. Med.
Sec. Precision Medicine
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1511339

Corrigendum: The Molecular Tumor Board as a Step in the Cancer Patient's Management: A Southern Italian Experience

Provisionally accepted
Stefania Tommasi Stefania Tommasi *
  • Bari John Paul II Cancer Institute, National Cancer Institute Foundation (IRCCS), Bari, Italy

This article is a correction to:

  1. The molecular tumor board as a step in cancer patient management: a southern Italian experience

    1. Read original article

The final, formatted version of the article will be published soon.

    • please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement.

    Keywords: Tumor board, molecular tumor board, precision medicine, comprehensive genomic profile, liquid biopsy

    Received: 14 Oct 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Tommasi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Stefania Tommasi, Bari John Paul II Cancer Institute, National Cancer Institute Foundation (IRCCS), Bari, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.